How is Hyperparathyroidism diagnosed?

Hyperparathyroidism is primarily diagnosed through biochemical testing that reveals elevated levels of parathyroid hormone (PTH) alongside high or inappropriately normal serum calcium levels. Imaging studies, such as sestamibi scans or neck ultrasounds, are then utilized to locate the specific parathyroid gland—or glands—causing the overproduction of the hormone.

How is Hyperparathyroidism diagnosed step-by-step?

The diagnostic process for Hyperparathyroidism begins when a physician notices persistent hypercalcemia (high blood calcium) during routine blood work or investigations for non-specific symptoms. Because Hyperparathyroidism can be subtle, clinicians must confirm the diagnosis through a specific set of laboratory measurements. Once the biochemical profile is established, the focus shifts to localization, which helps surgeons plan for potential curative procedures. Among the 154 members of the DiseaseMaps community currently living with Hyperparathyroidism, many report that this diagnostic transition from blood work to imaging is the most pivotal stage in their care journey.

What tests and examinations are used?

Diagnosis relies on a combination of blood chemistry and imaging. The following tests are standard in the clinical workup for Hyperparathyroidism:

• Serum Calcium and PTH: The hallmark test; high blood calcium combined with an elevated or "inappropriately normal" PTH level confirms the presence of the condition.


• 24-Hour Urine Collection: Used to measure calcium excretion, helping distinguish primary Hyperparathyroidism from familial hypocalciuric hypercalcemia (FHH).


• Sestamibi Scan: A nuclear medicine imaging test that highlights hyperactive parathyroid tissue.


• High-Resolution Neck Ultrasound: Used to visualize the parathyroid glands and identify potential adenomas or enlarged glands.


• 4D-CT Scan: Often used when initial imaging is inconclusive, providing detailed cross-sectional mapping of the neck.

Which specialists manage the diagnosis?

If you suspect you have Hyperparathyroidism, it is vital to consult an endocrinologist. These specialists are experts in hormonal imbalances and are best equipped to interpret complex lab panels. If a localized gland is found, an endocrine surgeon or an ENT surgeon specializing in neck surgery will typically lead the treatment phase. We validate the frustration many patients feel during the "diagnostic odyssey"—the time spent seeing multiple primary care doctors who may overlook the condition due to its vague symptom profile. Seeking an endocrinologist early can significantly shorten this delay.

What is the differential diagnosis?

Clinicians must carefully distinguish Hyperparathyroidism from other conditions that cause high calcium levels. These include malignancy (cancer-related hypercalcemia), sarcoidosis, vitamin D toxicity, and familial hypocalciuric hypercalcemia. Misdiagnosis is common because symptoms like fatigue, "brain fog," and bone pain are often dismissed as normal aging or stress. If your initial doctor is unfamiliar with the nuances of parathyroid hormone regulation, do not hesitate to seek a second opinion from a center of excellence.

Next steps

• Request a full metabolic panel including both ionized calcium and intact PTH levels from your primary care physician.


• If labs are abnormal, request a referral to an endocrinologist who specializes in calcium disorders.


• Document your symptoms, including any history of kidney stones, bone density loss, or recurring abdominal pain, to share with your specialist.


• Connect with the 154 members of the DiseaseMaps community who have navigated the diagnosis and treatment of Hyperparathyroidism.

Medical disclaimer: This information is for educational purposes and does not replace professional medical advice, diagnosis, or treatment; always consult with a qualified healthcare provider regarding your health conditions.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Hyperparathyroidism.


• Orphanet: Primary Hyperparathyroidism.


• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK): Hyperparathyroidism.


• OMIM (Online Mendelian Inheritance in Man): Parathyroid Hormone entry.